It was withdrawn during phase 3 due to heart failure problems, but is still in clinical development for alternative indications
What It Targets Our PT-141 peptide is designed to target: Hypoactive sexual desire disorder (HSDD) or chronically low libido that is distressing and not fully explained by pain, relationship conflict, or obvious hormonal deficits. Female sexual interest/arousal difficulties where desire and mental arousal are the main issues, even when lubrication or anatomy are otherwise normal. Men with low libido or mixed erectile challenges who have tried PDE5 inhibitors but still feel little desire or incomplete arousal. Couples who want a shared, timebound tool to reintroduce anticipation, spontaneity, and confidence as part of a broader intimacy reset
Routine calcitonin monitoring is not recommended in the general population, but any patient with neck mass or compressive symptoms while on therapy should be evaluated
These changes are easy to keep and make a big difference over time
However, this powder is still suitable for people who cannot consume gluten
Eating smaller meals and staying hydrated helps manage nausea during the adjustment period